FIELD: medicine.
SUBSTANCE: group of inventions includes method of weakness, muscular involvement or sarcopeny treatment and application of 2-methylene-19-nor-20(S)-1α,25 -dihydroxyvitamin D3 used for production of medicinal agent for these pathological states. Invention provides effective treatment of weakness, muscular involvement or sarcopeny due to capacity of 2- methylene-19-nor-20(S)-1α,25- dihydroxyvitamin D3 to actively mobilise calcium of bones combined with now activity of bowels calcium transportation.
EFFECT: agent is characterised with high efficiency.
18 cl, 2 ex, 2 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL FORMULATIONS AND METHODS INCLUDING COMBINATIONS OF 2-ALKYLIDEN DERIVATIVES OF 9-NOR-VITAMIN D AND BISPHOSPHONATE | 2004 |
|
RU2326695C2 |
| USE OF 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D3 TO TREAT SECONDARY HYPERPARATHYROIDISM | 2013 |
|
RU2666995C2 |
| HOMOLOGS OF 1α-HYDROXYVITAMIN D WITH SATURATED SIDE CHAIN, COMPOSITION PROMOTING STIMULATION AND ENHANCEMENT OF HUMAN LEUKEMIA MALIGNANT CELL DIFFERENTIATION, A METHOD OF STIMULATION AND ENHANCEMENT OF HUMAN LEUKEMIA MALIGNANT CELL DIFFERENTIATION | 1989 |
|
RU2057117C1 |
| COMPOUNDS, METHOD FOR THEIR PREPARING, METHODS OF TREATMENT | 2002 |
|
RU2296121C2 |
| NEW ANALOGUES OF VITAMIN D | 2001 |
|
RU2261244C2 |
| VITAMIN D ANALOG | 1991 |
|
RU2037484C1 |
| ANALOGS OF VITAMIN D3 | 2000 |
|
RU2235721C2 |
| PROCESS FOR PREPARING D-HYDROXY-24-EPIVITAMINE D | 1990 |
|
RU2065851C1 |
| 23-IN-VITAMIN D DERIVATIVE | 2011 |
|
RU2558362C2 |
| METHOD OF INDUCTION OF MALIGNANT CELL DIFFERENTIATION | 1990 |
|
RU2012558C1 |
